Search JIM Advanced Search

Journal of Integrative Medicine ›› 2024, Vol. 22 ›› Issue (5): 552-560.doi: 10.1016/j.joim.2024.08.005

• Original Clinical Research • Previous Articles     Next Articles

Hongjin Xiaojie Capsule, a Chinese patent medicine, for treating moderate to severe cyclical breast pain: A single-blind randomized controlled trial

Qiong Zhang a,b, Ying-yi Fan b, Xue-qing Wu c, Yan-dan Huo d, Chun-hui Wang e, Shi-bing Liang f, Ting Wang d, Rong Zhong c, Xuan Wang a,b, Bao-yong Lai e, Xiao-hua Pei b,e, Jian-ping Liu f   

  1. a Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China
    b Department of Breast, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, China
    c Department of Breast, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China
    d Department of Breast, Sichuan Second Hospital of Traditional Chinese Medicine, Chengdu 610014, Sichuan Province, China
    e Department of Breast, Xiamen Hospital, Beijing University of Chinese Medicine, Xiamen 361015, Fujian Province, China
    f Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
  • Received:2022-12-24 Accepted:2024-06-19 Online:2024-09-16 Published:2024-08-20
  • Contact: Xiao-hua Pei, E-mail: pxh_127@163.com Jian-ping Liu, E-mail: Liujp@bucm.edu.cn

Background
Moderate to severe breast pain has major effects on the quality of life for patients. Patent Chinese medicines are widely used in the treatment of breast pain due to their stable dosage form and good efficacy.

Objective
To evaluate the beneficial effects and safety of Hongjin Xiaojie Capsule (HJXJC), a Chinese patent medicine, for the treatment of cyclical breast pain.

Design, setting, participants and intervention
This is a multicenter, single-blind randomized controlled trial conducted in 3 medical centers in China from 2019 to 2021. Patients with moderate to severe cyclic breast pain were randomly divided into the intervention group (who took HJXJC, four capsules per dose, three times a day for 12 weeks) and the control group (waiting for the treatment) in a 1:1 ratio.

Main outcome measures
The primary outcome was pain duration, and the patients recorded measurements at baseline and at the end of weeks 4, 8, 12 and 16 on a patient log card.

Results
The full analysis set (FAS) population included 298 participants (intervention group, n = 150; control group, n = 148), while the per-protocol analysis set (PPS) included 274 participants. After 12 weeks, the duration of breast pain was significantly shorter in the intervention group (FAS: mean difference, –6.69; 95% CI, –7.58 to –5.80; P < 0.01, vs control. PPS: mean difference, –7.09; 95% CI, –8.01 to –6.16; P < 0.01, vs control). The Short-form McGill Pain Questionnaire (SF-MPQ) scores were significantly lower in the intervention group (FAS: mean difference, –12.55; 95% CI, –13.90 to –11.21; P < 0.01, vs control. PPS: mean difference, –13.07; 95% CI, –14.48 to –11.66; P < 0.01, vs control). The above indicators continued to be significantly different through week 16. Moreover, in the intervention group, breast lumps shrank after 12 weeks and the size of breast lumps was statistically smaller than that in the control group (P < 0.05), whereas the sizes of breast nodules and uterine fibroid showed no statistically significant difference compared with the control group (P > 0.05). At weeks 8 and 12, the dysmenorrhea scores in the intervention group were lower than those in the control group (P < 0.05). No obvious adverse reactions were observed in any group.

Conclusion

HJXJC can significantly shorten the duration of breast pain, reduce breast pain, reduce the size of breast lumps, and relieve dysmenorrhea. However, it has no significant effect on the size of breast nodules or uterine fibroid.


Trial registration

This trial has been registered at the ISRCTN Registry. Number: ISRCTN44184398.

Key words: Hongjin Xiaojie Capsule, Cyclical breast pain, Randomized controlled trial, Traditional Chinese medicine

[1] Hui-zhi Zhu, Cheng-yi Li, Liang-ji Liu, Jia-bing Tong, Zhi-hui Lan, Shu-guang Tian, Qiao Li, Xiang-li Tong, Ji-feng Wu, Zhen-gang Zhu, Su-yun Li, Jian-sheng Li. Efficacy and safety of Qingfei Huatan formula in the treatment of acute exacerbation of chronic obstructive pulmonary disease: A multi-centre, randomised, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2024, 22(5): 561-569.
[2] Ya-nan Yang, Jia-guo Zhan, Ying Cao, Chong-ming Wu. From ancient wisdom to modern science: Gut microbiota sheds light on property theory of traditional Chinese medicine. Journal of Integrative Medicine, 2024, 22(4): 413-444.
[3] Hao Wang, Si-ting Chen, Xiao-jie Ding, Le Kuai, Liang Hua, Xin Li, Yi-fei Wang, Ming Zhang, Bin Li, Rui-ping Wang, Mi Zhou. Efficacy and safety of Huzhang Granule, a compound Chinse herbal medicine, for acute gouty arthritis: A double-blind, randomized controlled trial. Journal of Integrative Medicine, 2024, 22(3): 270-278.
[4] Tong-yi Zhou, Na Tian, Liu Li, Rong Yu. Iridoids modulate inflammation in diabetic kidney disease: A review. Journal of Integrative Medicine, 2024, 22(3): 210-222.
[5] Betty H Wang, Ya-li Lin, Yin-yan Gao, Jin-lu Song, Lang Qin, Ling-qi Li, Wen-qi Liu, Claire CW Zhong, Mary Y Jiang, Chen Mao, Xiao-bo Yang, Vincent CH Chung, Irene XY Wu. Trial characteristics and treatment effect estimates in randomized controlled trials of Chinese herbal medicine: A meta-epidemiological study. Journal of Integrative Medicine, 2024, 22(3): 223-234.
[6] Jia-jia Wu, Tian-yi Zhang, Ying-hui Qi, Min-yan Zhu, Yan Fang, Chao-jun Qi, Li-ou Cao, Ji-fang Lu, Bo-han Lu, Lu-min Tang, Jian-xiao Shen, Shan Mou. Efficacy and safety of Yiqi Peiyuan granules for improving the short-term prognosis of patients with acute kidney injury: A multicenter, double-blind, placebo-controlled, randomized trial. Journal of Integrative Medicine, 2024, 22(3): 279-285.
[7] Peng Wang, Jing Hong, Zhu-qian Tang, Bi-zhen Gong, Xiao-rong Qi, Han Jiang, Bo Pan, Qi Chen. The acceptance of traditional Chinese medicine among patients with Parkinson's disease: A hospital survey. Journal of Integrative Medicine, 2024, 22(2): 180-187.
[8] Li-ying Liu, Yang Su, Rong-rong Wang, Yuan-yuan Lai, Lei Huang, Yi-ting Li, Xin-yue Tao, Meng-hua Su, Xiao-yan Zheng, Shi-chen Huang, Yong-na Wu, Si-yi Yu, Fan-rong Liang, Jie Yang. Transcutaneous electrical acupoint stimulation benefits postoperative pain relief of oocyte retrieval: A randomized controlled trial. Journal of Integrative Medicine, 2024, 22(1): 32-38.
[9] Rosemary Arnold, Jenifer Murphy-Smith, Chee H. Ng, David Mischoulon, Gerard J. Byrne, Chad A. Bousman, Con Stough, Michael Berk, Jerome Sarris. Predictors of the placebo response in a nutraceutical randomized controlled trial for depression. Journal of Integrative Medicine, 2024, 22(1): 46-53.
[10] Jun-yan He, Xiao-yu Tu, Zi-fei Yin, Hui Mu, Ming-jun Luo, Xing-yu Chen, Wei-bin Cai, Xue Zhao, Can Peng, Fan-fu Fang, Can Lü, Bai Li. Short-term effects of cupping and scraping therapy for chronic nonspecific low-back pain: A prospective, multicenter randomized trial. Journal of Integrative Medicine, 2024, 22(1): 39-45.
[11] Monika Rybicka, Jing Zhao, Karolina Piotrowicz, Sara Ptasnik, Kamila Mitka, Magdalena Kocot-Kępska, Ka-Kit Hui. Promoting whole person health: Exploring the role of traditional Chinese medicine in Polish healthcare. Journal of Integrative Medicine, 2023, 21(6): 509-517.
[12] Dong Kee Jang, Jun Kyu Lee, Chan Yung Jung, Kyung Ho Kim, Ha Ra Kang, Yeon Sun Lee, Jong Hwa Yoon, Kwang Ro Joo, Min Kyu Chae, Yong Hyeon Baek, Byung-Kwan Seo, Sang Hyub Lee, Chiyeon Lim. Electroacupuncture for abdominal pain relief in patients with acute pancreatitis: A three-arm randomized controlled trial. Journal of Integrative Medicine, 2023, 21(6): 537-542.
[13] Xiao-cong Wang, Xiao-yu Liu, Kang-le Shi, Qing-gang Meng, Yue-fan Yu, Shi-yao Wang, Juan Wang, Chang Qu, Cong Lei, Xin-ping Yu. Blinding assessment in clinical trials of traditional Chinese medicine: Exploratory principles and protocol. Journal of Integrative Medicine, 2023, 21(6): 528-536.
[14] Jian-sheng Li, Hai-long Zhang, Wen Guo, Lu Wang, Dong Zhang, Li-min Zhao, Miao Zhou. Efficacy and safety of Kangxian Huanji Granule as adjunctive treatment in acute exacerbation of idiopathic pulmonary fibrosis: An exploratory randomized controlled trial. Journal of Integrative Medicine, 2023, 21(6): 543-549.
[15] Liang-zhen You, Qian-qian Dai, Xiao-ying Zhong, Dong-dong Yu, He-rong Cui, Yi-fan Kong, Meng-zhu Zhao, Xin-yi Zhang, Qian-qian Xu, Zhi-yue Guan, Xu-xu Wei, Xue-cheng Zhang, Song-jie Han, Wen-jing Liu, Zhao Chen, Xiao-yu Zhang, Chen Zhao, Ying-hui Jin, Hong-cai Shang. Clinical evidence of three traditional Chinese medicine drugs and three herbal formulas for COVID-19: A systematic review and meta-analysis of the Chinese population. Journal of Integrative Medicine, 2023, 21(5): 441-454.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[2] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[3] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[4] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[5] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[6] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[7] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[8] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[9] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[10] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4